Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44393 clinical trials with a EudraCT protocol, of which 7405 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,393)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,393 result(s) found. Displaying page 1,441 of 2,220.

EudraCT Number: 2015-002465-28

Sponsor Protocol Number: ICANMINI

Start Date*: 2016-02-19

Sponsor Name:Klinikum der Universität München

Full Title: Anti-donor alloreactivity-guided CNI minimization versus unguided standard triple therapy in living-donor kidney transplantation

Medical condition: Renal transplantation

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004865	10023438	Kidney transplant	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2017-001272-40

Sponsor Protocol Number: CQAW039A2317

Start Date*: 2018-01-18

Sponsor Name:Novartis Pharma AG

Full Title: A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled as...

Medical condition: Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003553	Asthma	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) ES (Completed) BG (Completed) DE (Completed) HU (Completed) IT (Completed) RO (Completed)

Trial results: View results

EudraCT Number: 2016-000740-34	Sponsor Protocol Number: EPITBA12	Start Date*: 2017-09-28
Sponsor Name:Dr. Borja Maroto Rodríguez
Full Title: Treatment of functional EPIFORA with Botulinum Toxin versus lateral tarsal strip
Medical condition: Functional Epifora
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2018-001282-17	Sponsor Protocol Number: E7389-G000-223	Start Date*: 2018-03-23
Sponsor Name:Eisai Inc.
Full Title: A Phase 2, Multicenter, Open-label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma S...
Medical condition: Relapsed/Refractory Rhabdomyosarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Ewing Sarcoma
Disease:
Population Age: Infants and toddlers, Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: View results

EudraCT Number: 2006-001108-35

Sponsor Protocol Number: NRA 6290010

Start Date*: 2006-07-03

Sponsor Name:Clinic of University of Wuerzburg

Full Title: CHANGES OF LEFT VENTRICULAR MASS AND CARDIAC FUNCTION IN PATIENTS WITH ACTIVE ACROMEGALY DURING TREATMENT WITH THE GROWTH HORMONE RECEPTOR ANTAGONIST PEGVISOMANT: AN OPEN-LABELLED, PROSPECTIVE STUDY

Medical condition: Somavert (Pegvisomant) is approved for the treatment of acromegalic patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapy as Somatostatin Ana...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10061835		llt

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-019865-26

Sponsor Protocol Number: ES-CO2

Start Date*: 2010-07-15

Sponsor Name:Estetra S.A.

Full Title: A randomised, open-label, multi-centre, dose-finding study to evaluate cycle control of 15 mg or 20 mg estetrol combined with either 150 μg levonorgestrel or 3 mg drospirenone, compared to a combin...

Medical condition: Only healthy premenopausal volunteers will participate in this clinical trial. Intended indication: contraception.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10036556	Pregnancy	LLT

Population Age: Adults

Gender: Female

Trial protocol: FI (Completed)

Trial results: View results

EudraCT Number: 2008-001952-32	Sponsor Protocol Number: ACA-NETH-07-14	Start Date*: 2008-11-07
Sponsor Name:Radboud University Nijmegen Medical Centre - Department of Dermatology
Full Title: The effect of adalimumab on immune markers in lesional psoriatic skin.
Medical condition: Plaque psoriasis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: View results

EudraCT Number: 2014-001957-17

Sponsor Protocol Number: DFNS02

Start Date*: 2015-10-21

Sponsor Name:Umeå University Hospital

Full Title: THE EFFECT OF DIFLUNISAL ON FAMILIAL TRANSTHYRETIN AMYLOIDOSIS: An open label phase III extension study of the diflunisal trials (IND 68092 and DFNS01), and an open label observational study on p...

Medical condition: Familial transthyretin amyloidosis complicated by cardiomyopathy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004850	10019893	Hereditary neuropathic amyloidosis, Swedish type	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2009-011858-17

Sponsor Protocol Number: PR3095

Start Date*: 2009-09-25

Sponsor Name:Pantarhei Bioscience BV [...]

Full Title: A dose finding study with an active control group (Yasmin) to assess the contraceptive efficacy and the efficacy on liver function of estetrol combined with 3 mg drospirenone by daily oral administ...

Medical condition: Only healthy premenopausal volunteers will participate in this clinical trial. Intended indication: contraception.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10036556	Pregnancy	LLT

Population Age: Adults

Gender: Female

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2007-005476-14	Sponsor Protocol Number: PR3081	Start Date*: 2007-11-09
Sponsor Name:Pantarhei Bioscience BV
Full Title: A feasibility study into the contraceptive effect of estetrol alone or combined with either progesterone or desogestel by daily oral administration to healthy female volunteers for 28 days
Medical condition: Only healthy volunteers will participate in this clinical trial. Intended indication: contraception.
Disease:
Population Age: Adults		Gender: Female
Trial protocol: NL (Completed)
Trial results: View results

EudraCT Number: 2015-002361-32

Sponsor Protocol Number: 201810

Start Date*: 2016-04-05

Sponsor Name:GlaxoSmithKline Research & Development Ltd

Full Title: A multi-center, randomized, double-blind, placebo controlled, parallel group study to compare cessation versus continuation of long-term mepolizumab treatment in patients with severe eosinophilic a...

Medical condition: severe eosinophilic asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10038738 - Respiratory, thoracic and mediastinal disorders	10003553	Asthma	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) NL (Completed) RO (Ongoing) FR (Completed) PL (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2009-012013-22

Sponsor Protocol Number: BILA-3009/PED

Start Date*: 2009-12-09

Sponsor Name:FAES FARMA S.A.

Full Title: A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children from 2 to <12 Years of age with Allergic Rhinoconjunctivitis or Chronic Ur...

Medical condition: Allergic Rhinoconjunctivitis and chronic urticaria

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10001728	Allergic rhinoconjunctivitis	LLT
	12.0		10009159	Chronic urticaria	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: DE (Completed) ES (Completed) SE (Completed)

Trial results: View results

EudraCT Number: 2015-004195-30

Sponsor Protocol Number: ABX464-004

Start Date*: 2016-05-24

Sponsor Name:Abivax

Full Title: A multi-center, randomized, double-blind, placebo-controlled Phase IIa trial to compare the safety of ABX464 given at a fixed dose to placebo in fully controlled HIV infected patients treated with ...

Medical condition: Human Immunodeficiency Virus (HIV)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004862	10020443	Human immunodeficiency virus syndrome	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: BE (Completed) ES (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2012-003426-24	Sponsor Protocol Number: CTU079G	Start Date*: 2013-02-13
Sponsor Name:Riemser Pharma GmbH
Full Title: A multicentre double blind placebo controlled clinical trial to assess efficacy and safety of Alvalin® (cathine hydrochloride) vs. placebo in 265 obese patients/group with a body mass index (BMI) b...
Medical condition: diet-related obesity diagnosed by BMI of 30 to 45 kg/m²
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2016-002642-23	Sponsor Protocol Number: NVD-CLN01	Start Date*: 2016-11-28
Sponsor Name:Novadip Biosciences
Full Title: A prospective multi-centre, randomised, controlled study to evaluate the safety and preliminary effectiveness of NVD-001 for the treatment of low grade degenerative lumbar spondylolisthesis by inte...
Medical condition: Patients diagnosed with symptomatic degenerative spondylolisthesis grade I or II with an indication for spinal fusion of one vertebral segment (L1-S1).
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed) PL (Completed) CZ (Completed)
Trial results: View results

EudraCT Number: 2007-005523-15	Sponsor Protocol Number: ulcn0107	Start Date*: 2008-07-17
Sponsor Name:Radboud University Medical Centre
Full Title: A phase II study of carboplatin –paclitaxel with bevacizumab followed by the addition of erlotinib to bevacizumab beyond progression in patients with locally advanced and/or metastatic non-small ce...
Medical condition: advanced non-small cell lung cancer
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2022-000842-14	Sponsor Protocol Number: TBCH2022	Start Date*: 2022-07-01
Sponsor Name:Dra.Margarita Ramirez&Dra.Ifara Sánchez
Full Title: Trial study to evaluate the effectiveness of botulinum toxin A (incobotulinumtoxin) injection in reducing the pain and size of painful scars (including hypertrophic and keloid scars)
Medical condition: painful scars
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-006908-32

Sponsor Protocol Number: PNEUMONOVA

Start Date*: 2022-07-01

Sponsor Name:Sonia Luque Pardos

Full Title: Intrapulmonary penetration of ceftolozane / tazobactam and ceftazidime / avibactam administered in continuous infusion in critically ill patients with nosocomial pneumonia

Medical condition: Nosocomial pneumonia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004862	10052596	Nosocomial pneumonia	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-004819-12

Sponsor Protocol Number: FullResponders

Start Date*: 2018-01-10

Sponsor Name:OSPEDALE SAN RAFFAELE

Full Title: Discontinuation of first-line disease modifying treatment (DMT) in long-term full responders MS patients: a multicentre randomized clinical trial.

Medical condition: Relapsing-Remitting multiple sclerosis (RR-MS),

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029205 - Nervous system disorders	10063399	Relapsing-remitting multiple sclerosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2021-005874-24	Sponsor Protocol Number: PEI004/2021	Start Date*: 2022-07-01
Sponsor Name:Juan Enrique Domínguez Muñoz
Full Title: Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer
Medical condition: pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Thu Apr 02 01:18:19 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA